Title
mHealth Technology as a Persuasive Tool for Treatment, Care and Management of Persons Living with HIV
Date Issued
22 June 2015
Access level
open access
Resource Type
journal article
Author(s)
Columbia University
Publisher(s)
Springer New York LLC
Abstract
Mobile health (mHealth) technology can be a valuable tool in the management of chronic illnesses, including HIV. Qualitative research methods were used to identify the desired content and features of a mobile app for meeting and improving the healthcare needs of persons living with HIV (PLWH). We conducted six focus group sessions with 50 English-or Spanish-speaking PLWH in New York City. To inform data analysis and to illustrate how mHealth technology can be used as a persuasive strategy for improving the health of PLWH, we integrated Fogg’s functional role triad for computing technology model with the self-determination theory to illustrate how mHealth technology can be used as a persuasive strategy for improving the health of PLWH. Participants suggested several tools for meeting their healthcare needs, including: reminders/alerts, lab results tracking, and notes on health status. mHealth technology can function as a social actor by providing chat boxes/forums, testimonials of lived experiences, and personal outreach. Examples of media that can be used as a persuasive technology include games/virtual rewards, coding of health tasks, and simulations on how to connect with PLWH. Findings from these focus groups can be used to design a mobile app for PLWH that is targeted to meet their healthcare needs.
Start page
81
End page
89
Volume
19
Language
English
OCDE Knowledge area
Ciencias socio biomédicas (planificación familiar, salud sexual, efectos políticos y sociales de la investigación biomédica)
Subjects
Scopus EID
2-s2.0-84937635803
PubMed ID
Source
AIDS and Behavior
ISSN of the container
10907165
Sponsor(s)
This publication was supported by a cooperative agreement between Columbia University School of Nursing and the Centers for Disease Control and Prevention (CDC; 1U01PS00371501; PI: R Schnall). The authors would like to acknowledge Jocelyn Patterson Mosley, Monique Carry and Deborah Gelaude at the Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention, Prevention Research Branch, Atlanta, GA for their contributions to this project. The findings and conclusions in this report do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Sources of information:
Directorio de Producción Científica
Scopus